Chris H. Takimoto's most recent trade in Alx Oncology Holdings Inc was a trade of 40,400 Common Stock (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Chris H. Takimoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Common Stock (right to buy) | |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 13 Sep 2024 | 1,487 | 154,331 (0%) | 0% | 11.5 | 17,158 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Jul 2024 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 43,750 | 139,568 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 16,250 | 155,818 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 5.02 per share. | 14 Jun 2024 | 3,000 | 97,388 (0%) | 0% | 5.0 | 15,060 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 14 Jun 2024 | 1,570 | 95,818 (0%) | 0% | 7.6 | 11,893 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 13 Mar 2024 | 2,889 | 96,923 (0%) | 0% | 9.9 | 28,529 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.17 per share. | 13 Mar 2024 | 2,535 | 94,388 (0%) | 0% | 10.2 | 25,782 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 92,500 | 92,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Chris H. Takimoto | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 46,250 | 99,812 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 23 May 2023 | 1,244 | 54,757 (0%) | 0% | 12.3 | 15,302 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 11.71 per share. | 23 May 2023 | 962 | 56,001 (0%) | 0% | 11.7 | 11,265 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2023 | 15 | 54,742 (0%) | 0% | 13 | 195 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 52,500 | 52,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 26,250 | 55,039 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.73 per share. | 14 Mar 2023 | 1,768 | 28,789 (0%) | 0% | 18.7 | 33,118 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 16 Dec 2022 | 3,492 | 32,495 (0%) | 0% | 18.8 | 65,561 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.36 per share. | 16 Dec 2022 | 1,938 | 30,557 (0%) | 0% | 19.4 | 37,519 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 23 Nov 2022 | 600 | 36,264 (0%) | 0% | 21.4 | 12,826 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 23 Nov 2022 | 277 | 35,987 (0%) | 0% | 22.0 | 6,092 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 24 May 2022 | 938 | 36,864 (0%) | 0% | 17.1 | 16,043 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 12.38 per share. | 13 May 2022 | 825 | 37,802 (0%) | 0% | 12.4 | 10,214 | Common Stock |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 14,477 | 36,977 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 12,500 | 22,500 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Chris H. Takimoto | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |